Joe O'Neill is a board certified internist with extensive clinical, leadership and management skills.
He is currently a Professor of Medicine at the University of Maryland at Baltimore and is Director Global Health Initiatives in the offices of the President of the University and Dean of the School of Medicine.
He is a founding member of the board of the Maryland Global Initiatives Corporation, a non-profit subsidiary of the University of Maryland furthering University interests around the globe.
He was the only physician on the White House Domestic Policy Council during the first term of the George W. Bush administration and was intimately involved in all health related issues that reached that level of policy review.
He was credited by the President as having been the "architect" of his Emergency Plan for AIDS Relief - the largest global health initiative in history (now $48 billion).
designed the plan, secured White House support for it, led the public and Congressional negotiations needed to secure its passage, conceived its implementation strategy, and executed its initial operations.
provided the leadership necessary to coordinate efforts of numerous Federal and private agencies and was instrumental in securing FDA review, for the first time, of generic pharmaceuticals used outside of the United States- thereby dampening efforts to release poor quality knock off medications to the developing world market.
He has held fulfilled senior management and policy roles in the Clinton and Bush administrations including the $31 billion Health and Human Services HIV/AIDS portfolio (overseeing NIH, FDA and other relevant agencies); the Ryan White CARE Act programs; the National Organ Transplant Program and Bone Marrow Registry; the National Tele-Medicine initiative for the Department of Health and Human Services and others.
Dr. O'Neill has been CEO of a publically traded biotechnology corporation and has worked closely with and advised venture and other funders on a variety of early stage endeavors.
As CEO he led a reorganization, rebranding and strategic repurposing of the company, shifting from primarily an HIV vaccine agenda to one that focused on autoimmune diseases.
leadership the corporation designed and instigated two phase II trials and three pre-clinical investigations.
As a consultant to the vice-president for economic development at the University of Illinois he led the strategic planning for a drug discovery center, mobilizing university, public and private funding.
Dr. O'Neill holds degrees in Business Administration, Public Health, Health Sciences, and Medicine from the Universities of California at Berkeley and San Francisco.
He completed residency and served as chief resident for the department of medicine at the University of Washington in Seattle where he was elected into the Alpha Omega Alpha medical honor society.
He serves on boards of several NGOs including the The Jonas Salk Legacy Foundation, and the Diana, Princess of Wales Fund in the U.K.
has appeared on ABC Nightline, PBS's News Hour and other venues.
Dr. Joe O'Neill acted as an advisor to the Board of Directors of the African Palliative Care Association, until September 2010 when he became a Board Member.